Long-term outcome of transvenous pacemaker implantation in infants: a retrospective cohort study
Authors:
- 31 May 2016
- journal article
- research article
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 19 (4) , euw031-587
Abstract
Aim Evaluation of long-term outcome of transvenous pacemaker (PM) implantation in infants. Methods and results A retrospective analysis of all transvenous PM implantations in infants <10 kg between September 1997 and October 2001 was made. Indications for PM implantation, age at implantation, and determinants of long-term outcome including cardiac function, PM function, and PM (system) complications were noted. Seven patients underwent transvenous VVI(R) PM implantation. Median age at implantation was 3 days (range: 1 day to 14 months), median weight 3.5 kg (range: 2.3–8.7 kg), and median follow-up 14 years (range: 12.3–16.3 years). Pacemaker indications were congenital complete atrioventricular block ( n = 4), long QT syndrome with heart block ( n = 2), and post-operative complete atrioventricular block with sinus node dysfunction ( n = 1). No procedural complications were noted. Today all patients are alive and symptom free with good PM and cardiac function. Two patients underwent PM generator relocation for imminent skin necrosis and skin traction. Two patients suffered from asymptomatic left subclavian vein occlusion and developed thrombosis on the PM electrode. Three patients were converted to an epicardial PM system, due to atrial perforation after upgrading procedure ( n = 1), syncope with need for implantable cardioverter defibrillator implantation ( n = 1), and systolic dysfunction with development of dilated cardiomyopathy, which normalized under cardiac resynchronization therapy pacing ( n = 1). Two patients needed atrioventricular (AV) valve repair for severe insufficiency. Two patients underwent repositioning of dysfunctional PM leads. In five patients, transvenous leads were removed. Indications were elective lead replacement ( n = 1), atrial perforation ( n = 1), and switch to an epicardial system ( n = 3). Conclusion Transvenous PM implantation in infants (<10 kg) is associated with a high incidence of vascular occlusion, thrombosis, and severe atrioventricular valve regurgitation during long-term follow-up. We advocate an epicardial approach for PM implantation in small children.Keywords
This publication has 18 references indexed in Scilit:
- Pharmacological and non-pharmacological therapy for arrhythmias in the pediatric population: EHRA and AEPC-Arrhythmia Working Group joint consensus statementEP Europace, 2013
- Permanent Cardiac Pacing in Pediatric PatientsPediatric Cardiology, 2012
- Cardiac pacing in infants and childrenHeart, 2010
- Leadless Pacing of the Heart Using Induction Technology: A Feasibility StudyPacing and Clinical Electrophysiology, 2009
- Equivalent Performance of Epicardial Versus Endocardial Permanent Pacing in Children: A Single Institution and Manufacturer ExperienceThe Annals of Thoracic Surgery, 2008
- Age, Size, and Lead Factors Alone Do Not Predict Venous Obstruction in Children and Young Adults with Transvenous Lead SystemsJournal of Cardiovascular Electrophysiology, 2006
- Endocardial Pacemaker Implantation in Infants Weighing ≤ 10 KilogramsPacing and Clinical Electrophysiology, 2004
- Twenty years experience with pediatric pacing: epicardial and transvenous stimulationEuropean Journal of Cardio-Thoracic Surgery, 2000
- Risk Factors for Venous Obstruction in Children with Transvenous Pacing LeadsPacing and Clinical Electrophysiology, 1997
- Long-term transvenous pacing in children weighing ten kilograms or lessInternational Journal of Cardiology, 1987